Report cover image

Allergic Rhinitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Publisher Fairfield Market Research
Published Mar 12, 2024
Length 81 Pages
SKU # FCSL18644918

Description

Allergic Rhinitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global allergic rhinitis treatment market is on the brink of significant expansion, driven largely by the prevalence of perennial allergic rhinitis. As per recent analysis, the perennial allergic rhinitis segment is poised to emerge as the largest segment in the market by disease type, constituting close to 47% market share. This segment is expected to witness a steady growth trajectory over the forecast period 2024-2031.

Rising Demand and Lucrative Opportunities

The perennial allergic rhinitis segment is anticipated to offer the most lucrative opportunities within the global allergic rhinitis treatment market, boasting a market attractiveness index of 1.5. A burgeoning patient pool coupled with a growing prevalence of perennial allergic rhinitis is expected to fuel the demand for treatment options in the coming years. Notably, this segment is projected to create incremental opportunities between 2024 and 2031, representing more than 50% of the total incremental opportunity.

Healthcare Spending and Market Dynamics

The escalating global per capita healthcare spending is poised to play a pivotal role in driving the treatment of perennial allergic rhinitis. Increased healthcare expenditure reflects a growing awareness regarding the availability of diverse treatments and diagnostic methods for various diseases. Consequently, this trend is expected to stimulate demand for superior quality and rapid diagnostic techniques, presenting robust growth prospects for players operating in the perennial allergic rhinitis treatment segment.

Impact of Respiratory Diseases

Respiratory diseases, including perennial allergic rhinitis, impose a substantial burden on society in terms of disability, premature mortality, and healthcare costs. The intertwined nature of perennial allergic rhinitis with allergic asthma further underscores its significance in the global allergic rhinitis treatment market. Moreover, the condition's prevalence is significantly impacting market dynamics, driving the quest for innovative treatment solutions.

Awareness Initiatives and Market Growth

Increasing awareness about perennial allergic rhinitis treatment among patients globally is another catalyst propelling market growth. Government organizations and advocacy groups have initiated awareness programs to educate the public about allergic rhinitis. For instance, Allergy UK conducts allergy awareness week annually, aimed at raising awareness about allergic conditions, including perennial allergic rhinitis.

Key Companies:
• Merck & Co.
• Boehringer Ingelheim
• AstraZeneca
• GlaxoSmithKline PLC
• Sanofi S.A.
• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Alcon (Novartis AG)
• Others

Market Segmentation:

By Treatment Type
• Immunotherapy
• Sublingual Immunotherapy
• Allergy Shots
• Anti Histamines
• Decongestants
• Leukotriene Receptor Antagonists
• Corticosteroids

By Disease Type
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis

By Route of Administration
• Oral
• Nasal
• Intraocular
• Intravenous

By Distribution Channel
• Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East and Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.

Table of Contents

81 Pages
1. Executive Summary
1.1. Global Allergic Rhinitis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Allergic Rhinitis Market Outlook, 2018 – 2031
3.1. Global Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Immunotherapy
3.1.1.2. Sublingual Immunotherapy
3.1.1.3. Allergy Shots
3.1.1.4. Anti Histamines
3.1.1.5. Decongestants
3.1.1.6. Leukotriene Receptor Antagonists
3.1.1.7. Corticosteroids
3.2. Global Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Seasonal Allergic Rhinitis
3.2.1.2. Perennial Allergic Rhinitis
3.2.1.3. Occupational Allergic Rhinitis
3.3. Global Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Oral
3.3.1.2. Nasal
3.3.1.3. Intraocular
3.3.1.4. Intravenous
3.4. Global Allergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. Pharmacies
3.4.1.2. Hospital Pharmacies
3.4.1.3. Online Pharmacies
3.5. Global Allergic Rhinitis Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Allergic Rhinitis Market Outlook, 2018 – 2031
4.1. North America Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Immunotherapy
4.1.1.2. Sublingual Immunotherapy
4.1.1.3. Allergy Shots
4.1.1.4. Anti Histamines
4.1.1.5. Decongestants
4.1.1.6. Leukotriene Receptor Antagonists
4.1.1.7. Corticosteroids
4.2. North America Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Seasonal Allergic Rhinitis
4.2.1.2. Perennial Allergic Rhinitis
4.2.1.3. Occupational Allergic Rhinitis
4.3. North America Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Oral
4.3.1.2. Nasal
4.3.1.3. Intraocular
4.3.1.4. Intravenous
4.4. North America Allergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. Pharmacies
4.4.1.2. Hospital Pharmacies
4.4.1.3. Online Pharmacies
4.5. North America Allergic Rhinitis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
4.5.1.4. U.S. Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.5.1.5. Canada Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
4.5.1.8. Canada Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Allergic Rhinitis Market Outlook, 2018 – 2031
5.1. Europe Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Immunotherapy
5.1.1.2. Sublingual Immunotherapy
5.1.1.3. Allergy Shots
5.1.1.4. Anti Histamines
5.1.1.5. Decongestants
5.1.1.6. Leukotriene Receptor Antagonists
5.1.1.7. Corticosteroids
5.2. Europe Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Seasonal Allergic Rhinitis
5.2.1.2. Perennial Allergic Rhinitis
5.2.1.3. Occupational Allergic Rhinitis
5.3. Europe Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Oral
5.3.1.2. Nasal
5.3.1.3. Intraocular
5.3.1.4. Intravenous
5.4. Europe Allergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Pharmacies
5.4.1.2. Hospital Pharmacies
5.4.1.3. Online Pharmacies
5.5. Europe Allergic Rhinitis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.5.1. Key Highlights
5.5.1.1. Germany Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.2. Germany Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
5.5.1.3. Germany Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.4. Germany Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.5. U.K. Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.8. U.K. Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.9. France Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.10. France Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
5.5.1.11. France Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.12. France Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.13. Italy Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.14. Italy Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Allergic Rhinitis Market by Route of Administration, Value (US$Bn), 2018 - 2031
5.5.1.16. Italy Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.17. Turkey Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.18. Turkey Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
5.5.1.19. Turkey Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.20. Turkey Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.21. Russia Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.22. Russia Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.24. Russia Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.25. Rest of Europe Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
5.5.1.26. Rest of Europe Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
5.5.1.27. Rest of Europe Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
5.5.1.28. Rest of Europe Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Allergic Rhinitis Market Outlook, 2018 – 2031
6.1. Asia Pacific Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Immunotherapy
6.1.1.2. Sublingual Immunotherapy
6.1.1.3. Allergy Shots
6.1.1.4. Anti Histamines
6.1.1.5. Decongestants
6.1.1.6. Leukotriene Receptor Antagonists
6.1.1.7. Corticosteroids
6.2. Asia Pacific Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Seasonal Allergic Rhinitis
6.2.1.2. Perennial Allergic Rhinitis
6.2.1.3. Occupational Allergic Rhinitis
6.3. Asia Pacific Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Oral
6.3.1.2. Nasal
6.3.1.3. Intraocular
6.3.1.4. Intravenous
6.4. Asia Pacific Allergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. Pharmacies
6.4.1.2. Hospital Pharmacies
6.4.1.3. Online Pharmacies
6.5. Asia Pacific Allergic Rhinitis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.4. China Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.8. Japan Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.9. South Korea Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
6.5.1.10. South Korea Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
6.5.1.11. South Korea Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.12. South Korea Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.13. India Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
6.5.1.14. India Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.16. India Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.17. Southeast Asia Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
6.5.1.18. Southeast Asia Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
6.5.1.19. Southeast Asia Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.20. Southeast Asia Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
6.5.1.23. Rest of Asia Pacific Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
6.5.1.24. Rest of Asia Pacific Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Allergic Rhinitis Market Outlook, 2018 – 2031
7.1. Latin America Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Immunotherapy
7.1.1.2. Sublingual Immunotherapy
7.1.1.3. Allergy Shots
7.1.1.4. Anti Histamines
7.1.1.5. Decongestants
7.1.1.6. Leukotriene Receptor Antagonists
7.1.1.7. Corticosteroids
7.2. Latin America Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Seasonal Allergic Rhinitis
7.2.1.2. Perennial Allergic Rhinitis
7.2.1.3. Occupational Allergic Rhinitis
7.3. Latin America Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Oral
7.3.1.2. Nasal
7.3.1.3. Intraocular
7.3.1.4. Intravenous
7.4. Latin America Allergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Pharmacies
7.4.1.2. Hospital Pharmacies
7.4.1.3. Online Pharmacies
7.5. Latin America Allergic Rhinitis Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
7.5.1.2. Brazil Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
7.5.1.4. Brazil Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.1.5. Mexico Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
7.5.1.6. Mexico Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
7.5.1.8. Mexico Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.1.9. Argentina Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
7.5.1.10. Argentina Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
7.5.1.11. Argentina Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
7.5.1.12. Argentina Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
7.5.1.15. Rest of Latin America Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
7.5.1.16. Rest of Latin America Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Allergic Rhinitis Market Outlook, 2018 – 2031
8.1. Middle East & Africa Allergic Rhinitis Market Outlook, by Treatment Type, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Immunotherapy
8.1.1.2. Sublingual Immunotherapy
8.1.1.3. Allergy Shots
8.1.1.4. Anti Histamines
8.1.1.5. Decongestants
8.1.1.6. Leukotriene Receptor Antagonists
8.1.1.7. Corticosteroids
8.2. Middle East & Africa Allergic Rhinitis Market Outlook, by Disease Type, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Seasonal Allergic Rhinitis
8.2.1.2. Perennial Allergic Rhinitis
8.2.1.3. Occupational Allergic Rhinitis
8.3. Middle East & Africa Allergic Rhinitis Market Outlook, by Route of Administration, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Oral
8.3.1.2. Nasal
8.3.1.3. Intraocular
8.3.1.4. Intravenous
8.4. Middle East & Africa sAllergic Rhinitis Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmacies
8.4.1.2. Hospital Pharmacies
8.4.1.3. Online Pharmacies
8.5. Middle East & Africa Allergic Rhinitis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.5.1. Key Highlights
8.5.1.1. GCC Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
8.5.1.4. GCC Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.5. South Africa Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
8.5.1.6. South Africa Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
8.5.1.7. South Africa Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
8.5.1.8. South Africa Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.9. Egypt Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
8.5.1.12. Egypt Allergic Rhinitis Market by Distribution Channel, Value (US$Bn), 2018 - 2031
8.5.1.13. Nigeria Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
8.5.1.15. Nigeria Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
8.5.1.16. Nigeria Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.17. Rest of Middle East & Africa Allergic Rhinitis Market by Treatment Type, Value (US$ Bn), 2018 – 2031
8.5.1.18. Rest of Middle East & Africa Allergic Rhinitis Market by Disease Type, Value (US$ Bn), 2018 – 2031
8.5.1.19. Rest of Middle East & Africa Allergic Rhinitis Market by Route of Administration, Value (US$ Bn), 2018 – 2031
8.5.1.20. Rest of Middle East & Africa Allergic Rhinitis Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Route of Administration vs By Disease Type Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Merck & Co.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Boehringer Ingelheim
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. AstraZeneca
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. GlaxoSmithKline PLC
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Sanofi S.A.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Johnson & Johnson
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Teva Pharmaceutical Industries Ltd.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Alcon (Novartis AG)
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2.Report Assumptions 10.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us